help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on March 12, 2009, doi:10.1164/rccm.200810-1553OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Supplement
Right arrow All Versions of this Article:
200810-1553OCv1
179/12/1131    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hwang, S.-K.
Right arrow Articles by Cho, M.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hwang, S.-K.
Right arrow Articles by Cho, M.-H.
American Journal of Respiratory and Critical Care Medicine Vol 179. pp. 1131-1140, (2009)
© 2009 American Thoracic Society
doi: 10.1164/rccm.200810-1553OC


Original Article

Repeated Aerosol Delivery of Carboxyl-terminal Modulator Protein Suppresses Tumor in the Lungs of K-rasLA1 Mice

Soon-Kyung Hwang1, Hwang-Tae Lim1,2, Arash Minai-Tehrani1, Eun-Sun Lee1, Jongmin Park3, Seung Bum Park3, George R. Beck, Jr.4 and Myung-Haing Cho1,2

1 Laboratory of Toxicology, College of Veterinary Medicine, 2 Nano Systems Institute–National Core Research Center, and 3 Department of Chemistry, College of Natural Science, Seoul National University, Seoul, Korea; and 4 Division of Endocrinology, Metabolism and Lipids, Emory University School of Medicine, Atlanta, Georgia

Correspondence and requests for reprints should be addressed to Myung-Haing Cho, D.V.M., Ph.D., Laboratory of Toxicology, College of Veterinary Medicine, Seoul National University, Seoul 151-742, Korea. E-mail: mchotox{at}snu.ac.kr

Rationale: Difficulties in achieving long-term survival of patients with lung cancer treated with conventional therapies suggest that novel approaches are required. Recent advances in aerosol-mediated gene delivery have provided the possibility of an alternative for the safe and effective treatment of lung cancer.

Objectives: To investigate the repeated effect of carboxyl-terminal modulator protein (CTMP) on multistage lung tumorigenesis. In this study, we addressed this question by studying the effects of lentivirus-based CTMP in the lungs of 9- and 13-week-old K-rasLA1 mice, a model of lung cancer.

Methods: An aerosol of lentivirus-based CTMP was delivered into 9- and 13-week-old K-rasLA1 mice, a model of lung cancer, through a nose-only inhalation system twice a week for 4 weeks. The effects of CTMP on lung cancer progression and Akt-related signals were evaluated.

Measurements and Main Results: Long-term repeated delivery of CTMP effectively reduced tumor progression in the lungs at different stages of development. Lentiviral-CTMP inhibited protein synthesis and cell cycle and altered Akt signaling pathway in the lungs of 9-week-old K-rasLA1 mice, and increased apoptosis was observed in the lungs of 13-week-old K-rasLA1 mice.

Conclusions: Long-term repeated viral delivery of CTMP may provide a useful tool for designing lung tumor treatment.

Key Words: lentivirus • carboxyl-terminal modulator protein • lung cancer • K-rasLA1 mice • aerosol gene delivery


AT A GLANCE COMMENTARY

Scientific Knowledge on the Subject
Difficulties in achieving long-term survival of lung cancer patients require novel approaches for safe and effective treatment.

What This Study Adds to the Field
Long-term repeated viral delivery of carboxyl-terminal modulator protein may provide a useful tool for designing lung tumor treatment.

 






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2009 American Thoracic Society
  2nd Annual Dinner